Over 170 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.
Over 20 presentations, case studies and panel discussions focused on the key issues in the industry, from stem cell development and bioprocessing optimisation to commercial production and clinical trials.
2 interactive streams:
Stem Cell & iPSC Bioprocessing and Manufacturing
Stem Cell Therapy inc. Clinical & Commercialisation
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
Oxford Global Conferences are proud to present the 2nd Annual Stem Cell Congress, taking place on the 9th & 10th November 2015 in London. This event will be co-located with our prestigious 4th Annual Cell Culture & Bioprocessing Congress, as well as our new Cell and Gene Therapy Congress.
The global stem cell market is set to reach a value of well over $100 billion by 2019, with stem cell therapies alone surpassing an estimated $330 million by 2020. Stem cells are likely to be central to the future of medicine, and as the potential for medical applications progresses we are seeing an ever-increasing interest in stem cell research in industry as well as academia. Over two days, the Stem Cell Congress will give attendees the opportunity to hear from those at the forefront of stem cell research share their knowledge on current challenges and exciting developments, as well as the insights into the future of the industry.
The first day of the conference will look at the latest innovations in stem cell bioprocessing, including challenges with the upstream and downstream stages, meeting quality requirements, and efficient cell banking practices. Experts from academia, pharmaceutical and biotech organisations will present on the key topics in the industry today, ranging from novel reprogramming and transdifferentiation techniques, to the most effective methods to engineer mammalian stem cells or ensure controlled growth.
The second day of the Stem Cell Congress will address the major issues and opportunities in the field of stem cell therapies, including up to date clinical trial information and approaches to commercialisation. Our highly experienced panel will discuss techniques to build truly effective clinical trials, provide insights into approaches to optimising delivery of stem cell therapies, and discuss the latest in genome-editing for disease modelling.
Over two days, the congress will attract senior-level decision makers working at the cutting edge of the stem cell industry from the US and Europe. The programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, as well as ample networking opportunities, creating an ideal interactive platform for high-level scientific and business discussion.
Over 20 presentations, case studies and panel discussions focused on the key issues in the industry, from stem cell development and bioprocessing optimisation to commercial production and clinical trials.
2 interactive streams:
Stem Cell & iPSC Bioprocessing and Manufacturing
Stem Cell Therapy inc. Clinical & Commercialisation
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
Oxford Global Conferences are proud to present the 2nd Annual Stem Cell Congress, taking place on the 9th & 10th November 2015 in London. This event will be co-located with our prestigious 4th Annual Cell Culture & Bioprocessing Congress, as well as our new Cell and Gene Therapy Congress.
The global stem cell market is set to reach a value of well over $100 billion by 2019, with stem cell therapies alone surpassing an estimated $330 million by 2020. Stem cells are likely to be central to the future of medicine, and as the potential for medical applications progresses we are seeing an ever-increasing interest in stem cell research in industry as well as academia. Over two days, the Stem Cell Congress will give attendees the opportunity to hear from those at the forefront of stem cell research share their knowledge on current challenges and exciting developments, as well as the insights into the future of the industry.
The first day of the conference will look at the latest innovations in stem cell bioprocessing, including challenges with the upstream and downstream stages, meeting quality requirements, and efficient cell banking practices. Experts from academia, pharmaceutical and biotech organisations will present on the key topics in the industry today, ranging from novel reprogramming and transdifferentiation techniques, to the most effective methods to engineer mammalian stem cells or ensure controlled growth.
The second day of the Stem Cell Congress will address the major issues and opportunities in the field of stem cell therapies, including up to date clinical trial information and approaches to commercialisation. Our highly experienced panel will discuss techniques to build truly effective clinical trials, provide insights into approaches to optimising delivery of stem cell therapies, and discuss the latest in genome-editing for disease modelling.
Over two days, the congress will attract senior-level decision makers working at the cutting edge of the stem cell industry from the US and Europe. The programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, as well as ample networking opportunities, creating an ideal interactive platform for high-level scientific and business discussion.
